Sleep Quality
Conditions
Keywords
Sleep Quality, Photobiomodulation, Dry Float
Brief summary
The main objective of this study is to assess the impact of implementing photobiomodulation (PBM) therapy, either localized or whole body, or dry float on sleep quality in middle-aged and elderly individuals experiencing sleep disturbance. As a secondary objective we will analyze the effect of the treatments on other indices of recovery (subjective and objective) via physiological monitoring in middle-aged and elderly individuals experiencing sleep disturbance. The study will have 2 phases: Phase 1 will last 5 weeks and will serve as baseline data collection of sleep quality. Phase 2 contains the experimental conditions and will last 13 weeks. Cognitive, behavioral, and physiological tests will be done at baseline (week 1) and at the end of experimental period (week 18). Sleep tracking data will be collected daily.
Detailed description
In summary the study participants are expected to: * Wear a study provided smart ring (OURA Ring) through the end of the study period (at least 75% of the total study time) which measures sleep quantity/quality. * Keep their smart phones nearby and charged while wearing their devices. * Complete monthly surveys with questions about general well-being until the end of the study period. * Complete a testing battery consisting of cognitive tests, behavioral and mood questionnaires, qEEG and physical assessments, in the beginning and at the end of the study period. * Complete the designated experimental condition 2- 3x/week for 12 weeks (at least 75% of the total sessions), if applicable.
Interventions
DEVICENovoThor
Following the baseline block (first four weeks), participants will use the NovoThor device 2-3 times per week for 20 minute sessions at the WVU Rockefeller Neuroscience Institute.
DEVICEVieLight
Following the baseline block (first four weeks), participants will use the VieLight device 2-3 times per week for 20 minute sessions and may be completed at home.
DEVICEZeroBody
Following the baseline block (first four weeks), participants will use the Zerobody device 2-3 times per week for 20 minute sessions at the WVU Rockefeller Neuroscience Institute.
Sponsors
West Virginia University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
Yes
Inclusion criteria
* Male or female between 50-85 years of age * Able and willing to give informed consent * No significant untreated medical history
Exclusion criteria
* Have no mental or physical conditions that are deemed inappropriate for study participation at investigator's discretion.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in resting state electroencephalography (EEG) | Changes from baseline versus end of study week 18 | Electroencephalography (EEG) analysis looking for alterations in brain activity. A paired samples t-Test will be used to compare power activity at baseline and follow-up. |
| Changes in the Patient Health Questionnaire (PHQ-9) | Changes from baseline versus end of study week 18 | Participants will complete the Patient Health Questionnaire (PHQ-9) once a month. The higher the score, the more severe the symptoms of depression. Scores range from 5-9 = mild, 10-14 = moderate, 15-19 = moderate severe, 20-27 severe depression |
| Changes in total sleep via Oura Ring | Changes from baseline versus end of study week 18 | Oura Ring will be used to track total sleep throughout the study. Increased total sleep values will indicate better quality sleep and decrease total sleep values will indicate poorer sleep. |
| Changes in the Circadian Sleep Inventory | Changes from baseline versus end of study week 18 | Evaluate changes in the participants sleeping patterns. Higher values indicate poorer sleep quality. |
Countries
United States
Outcome results
None listed